Clinical Trials on ALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive NSCLC in Germany
Total 610 results
-
TakedaActive, not recruitingALK+ Advanced NSCLCSpain, China, Korea, Republic of, Taiwan, Hong Kong, Thailand, Italy, Romania, United States, Mexico, Croatia, Russian Federation, Argentina, Canada, Germany, France, Austria, Chile, Greece, Sweden
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerGermany
-
Boehringer IngelheimRecruitingSmall Cell Lung Carcinoma (SCLC)United Kingdom, Germany, France, Poland
-
Taiho Oncology, Inc.RecruitingAdvanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) MutationsUnited States, Japan, Spain, France, Australia, Italy, Korea, Republic of, United Kingdom, Canada, Germany, Turkey, Hong Kong
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerGermany
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerGermany
-
AIO-Studien-gGmbHMerck Sharp & Dohme LLCTerminatedMetastatic Squamous Non-small Cell Lung CancerGermany
-
University Hospital HeidelbergGerman Cancer Research Center; Heidelberg UniversityActive, not recruiting
-
University Hospital HeidelbergGerman Cancer Research Center; Heidelberg UniversityCompleted
-
Merck KGaA, Darmstadt, GermanyMerck Serono Co., Ltd., JapanCompleted
-
Taiho Oncology, Inc.RecruitingAdvanced or Metastatic NSCLS With Exon 20 Insertion MutationUnited States, Spain, Canada, Italy, Israel, Japan, United Kingdom, Korea, Republic of, Germany, France, Turkey, Belgium, Netherlands, Philippines, Poland, Singapore
-
iOMEDICO AGRoche Pharma AGCompletedExtensive-stage Small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Advanced (Locally Advanced and Inoperable or Metastatic), PD-L1 IC-positive TNBCGermany
-
Krankenhaus NordwestCompleted
-
AIO-Studien-gGmbHBoehringer IngelheimTerminatedNon-small-cell Lung Cancer With Somatic EGFR MutationsGermany
-
Daiichi Sankyo, Inc.CompletedNon-small Cell Lung CancerGermany
-
PD Dr. med. Wolfgang SchuetteEli Lilly and Company; Roche Pharma AGCompletedNon-squamous Non-small Cell Lung CancerGermany
-
Heidelberg UniversityUnknownNon Small Cell Lung CancerGermany
-
Hannover Medical SchoolTerminated
-
Bristol-Myers SquibbRecruiting
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingNon-squamous NSCLC | HER2 Exon 20 MutationKorea, Republic of, United States, Taiwan, Belgium, Spain, China, Australia, Turkey, Italy, France, Germany, Poland, Russian Federation
-
Taiho Oncology, Inc.Taiho Pharmaceutical Co., Ltd.TerminatedSmall Cell Lung Cancer (SCLC)Japan, Italy, Germany
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyActive, not recruitingAdvanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification | Lung Adenocarcinoma Stage IIIB/IVSpain, Taiwan, United States, Korea, Republic of, Netherlands, Israel, Belgium, Italy, China, France, Germany, Japan, Poland, Austria, Switzerland
-
Institut für Klinische Krebsforschung IKF GmbH...Roche Pharma AG; Thoraxklinik-Heidelberg gGmbHRecruitingNon-small Cell Lung CancerGermany
-
University Hospital HeidelbergLudwig-Maximilians - University of Munich; German Cancer Research Center; University...RecruitingNon-small Cell Lung CancerGermany
-
European Organisation for Research and Treatment...UnknownNon-small Cell Lung Cancer Stage I | Non-small Cell Lung Cancer Stage IIGermany, Belgium, United Kingdom, Switzerland
-
NovoCure GmbHActive, not recruitingBrain Metastases From Non-small Cell Lung Cancer (NSCLC)United States, China, Israel, Spain, Austria, Canada, Hong Kong, Germany, France, Bulgaria, Croatia, Hungary, Italy, Poland, Serbia
-
German Cancer Research CenterTerminatedNon-small Cell Lung CancerGermany
-
Eli Lilly and CompanyCompletedNon-Small-Cell Lung CancerGermany, Italy
-
University of CologneWithdrawnMelanoma | Non Small Cell Lung CancerGermany
-
AstraZenecaActive, not recruitingNSCLCFrance, Germany, Italy, Netherlands, United Kingdom, Belgium, Israel, Australia, Switzerland, Norway
-
AstraZenecaCompletedNSCLCFrance, Italy, Spain, Turkey, Belgium, Portugal, Greece, Germany
-
AmgenRecruitingSmall Cell Lung Cancer (SCLC)China, United States, Australia, Netherlands, Taiwan, Spain, Canada, Korea, Republic of, Turkey, Israel, Austria, Japan, France, United Kingdom, Germany, Belgium, Denmark, Czechia, Switzerland, Italy, Hungary, Ireland, Argentina, Brazil, Malays... and more
-
AstraZenecaTerminatedLung Cancer | Non-small Cell Lung CancerGermany
-
AstraZenecaRecruitingNSCLCChina, United States, United Kingdom, Korea, Republic of, Italy, Hungary, Spain, Vietnam, France, Brazil, Canada, Japan, Taiwan, Germany, Austria, Turkey, India, Peru, Poland, Sweden, Bulgaria, Greece, Mexico, Denmark
-
Arbeitsgemeinschaft Nuklearmedizin und Strahlentherapie...UnknownNon-small Cell Lung CancerGermany
-
Eli Lilly and CompanyCompletedNon-Small-Cell Lung CancerGermany
-
Novartis PharmaceuticalsCompletedNon Small Cell Lung CancerBelgium, Australia, Germany
-
BayerCompletedNon Small Cell Lung CancerFrance, Germany
-
Institut für Klinische Krebsforschung IKF GmbH...Active, not recruiting
-
Thoraxklinik-Heidelberg gGmbHCompletedNon Small Cell Lung CancerBelgium, Germany, Luxembourg
-
Merck Sharp & Dohme LLCCompletedSmall Cell Lung Cancer (SCLC)United States, Australia, Canada, Chile, France, Germany, Hungary, Ireland, Israel, Japan, Korea, Republic of, New Zealand, Poland, Russian Federation, Spain, Switzerland, Taiwan, Turkey, United Kingdom
-
Eli Lilly and CompanyCompletedHistological or Cytological Diagnosis of Locally Advanced or Metastatic NSCLC of Nonsquamous Histology and Not Amenable to Curative Therapy.Hungary, Germany, Austria, Spain, Sweden
-
Novartis PharmaceuticalsTerminatedNon-Small Cell Lunch CancerItaly, United States, Germany, Spain, Canada
-
CureVacCompletedNon Small Cell Lung CancerSwitzerland, Germany
-
Novartis PharmaceuticalsCompletedNon Small Cell Lung CancerAustralia, Germany, United States
-
AstraZenecaTerminatedSquamous Non Small Cell Lung CancerSpain, United States, Germany
-
Eli Lilly and CompanyWithdrawnMetastatic Squamous Non-Small Cell Lung Cancer | Locally Advanced Squamous Non-Small Cell Lung CancerItaly, Romania, Germany, Belgium, Russian Federation, United States, United Kingdom
-
Synta Pharmaceuticals Corp.TerminatedNon-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Stage IIIB | Non-small Cell Lung Cancer Stage IVUnited States, Belgium, Bosnia and Herzegovina, Canada, Croatia, Czech Republic, Germany, Poland, Romania, Russian Federation, Serbia, Spain, United Kingdom
-
Bristol-Myers SquibbCompletedNon-Small Cell Lung CancerGermany
-
PDC*line Pharma SASActive, not recruitingSafety, Immunogenicity and Preliminary Clinical Activity Study of PDC*lung01 Cancer Vaccine in NSCLCNon Small Cell Lung CancerBelgium, France, Netherlands, Germany, Poland